Press Resease

Thrombosis Drug Market by Drug Class (Factor Xa Inhibitor, Low Molecular Weight Heparin, and P2Y12 Platelet Inhibitor), by Indications (Pulmonary Embolism, Atrial Fibrillation, and Deep Vein Thrombosis), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017- 2024

Published Date: 14-Sep-2018 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-3363 Status : Published

Global thrombosis drug market expected to generate revenue of around USD 40934.75 million by end of 2024, growing at a CAGR of around 9.3% between 2018 and 2024. Thrombosis is a blood clot in the veins or arteries obstructing the blood flow in the circulatory system. It may be formed due to injury or some other reasons.

Description

The report covers forecast and analysis for the thrombosis drug market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the thrombosis drug market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the thrombosis drug market on a global level.

In order to give the users of this report a comprehensive view of the thrombosis drug market, we have included competitive landscape and analysis of Porter’s Five Forces model in the market. The study encompasses a market attractiveness analysis, where drug type, indication, distribution channel, and regional segmentation are benchmarked based on their market size, growth rate, and general attractiveness.

Global Thrombosis Drug Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments in the market, including acquisitions & mergers, new drug launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the market on the global and regional basis. 

The study provides a decisive view of the thrombosis drug market by segmenting the market based on drug type, indication, distribution channel, and regions. All the segments have been analyzed based on present and the future trends and the market are estimated from 2018 to 2024.
 
Based on drug type, the thrombosis drug market is segmented as Factor Xa Inhibitor, Low Molecular Weight Heparin, and P2Y12 Platelet Inhibitor. Based on the indication, the thrombosis drug market is segmented as pulmonary embolism, atrial fibrillation, and deep vein thrombosis. Based on distribution channel, thrombosis drug market is segmented as hospital pharmacies, retail pharmacies, and online pharmacies.

Increased prevalence of thrombosis is one of the major driving factors of thrombosis drug market. Increased awareness coupled with technological advancement and research and development activities carried out by the various companies also help companies to develop new medicines for the treatment of thrombosis. However, increased use of generic medicines influences the market growth during the forecast period.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further divided into major countries, including the U.S., Germany, France, the UK, China, Japan, India, and Brazil. This segment includes demand for thrombosis drug market based on individual segment and treatment in all the regions and countries.

The report also includes detailed profiles of end players such as GlaxoSmithKline Plc., Aspen Pharmacare Holdings Limited, Johnson & Johnson, Sanofi, AstraZeneca Plc, Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Baxter International Inc. and Pfizer, Inc., and others. 

This report segments the global thrombosis drug market as follows:

Global Thrombosis Drug Market: Drug Type Segment Analysis

  • Factor Xa Inhibitor
  • Low Molecular Weight Heparin
  • P2Y12 Platelet Inhibitor  

Global Thrombosis Drug Market: Indication Segment Analysis

  • Pulmonary Embolism
  • Atrial Fibrillation 
  • Deep Vein Thrombosis

Global Thrombosis Drug Market: Distribution Channel Segment Analysis

  • Hospital Pharmacies
  • Retail Pharmacies 
  • Online Pharmacies

Global Thrombosis Drug Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Thrombosis Drug Market, 2015 - 2024 (USD Billion)
    • 2.2. Global Thrombosis Drug Market: Snapshot
  •  
  • Chapter 3. Thrombosis Drug Market Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Thrombosis Drug Market drivers: Impact analysis
      • 3.2.2. Increased prevalence of thrombosis
      • 3.2.3. Research and development
    • 3.3. Market Restraints
      • 3.3.1. Increased use of generic drugs
    • 3.4. Opportunities
      • 3.4.1. Increasing demand of better treatment in emerging economies
    • 3.5. Porter's five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Drug Type
      • 3.6.2. Market attractiveness analysis, by Indication
      • 3.6.3. Market Attractiveness analysis, by Distribution Channel
      • 3.6.4. Market attractiveness analysis, by Regional Segment
  •  
  • Chapter 4. Global Thrombosis Drug Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Thrombosis Drug Market: company market share, 2015
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Drug Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development, Regional Expansion
  •  
  • Chapter 5. Global Thrombosis Drug Market - Drug Segment Analysis
    • 5.1. Global Thrombosis Drug Market: Drug overview
      • 5.1.1. Global Thrombosis Drug Market revenue share, by Drug, 2015 and 2024(USD Billion)
    • 5.2. Factor Xa Inhibitor
      • 5.2.1. Global Factor Xa Inhibitor market, 2015 - 2024(USD Billion)
    • 5.3. Low Molecular Weight Heparin
      • 5.3.1. Global Low Molecular Weight Heparin market, 2015 - 2024(USD Billion)
    • 5.4. P2Y12 Platelet Inhibitor
      • 5.4.1. Global P2Y12 Platelet Inhibitor market, 2015 - 2024(USD Billion)
  •  
  • Chapter 6. Global Thrombosis Drug Market - Indication Segment Analysis
    • 6.1. Global Thrombosis Drug Market: Indication overview
      • 6.1.1. Global Thrombosis Drug Market revenue share, by Indication , 2014 and 2024(USD Billion)
    • 6.2. Pulmonary Embolism
      • 6.2.1. Global Thrombosis Drug Market for Pulmonary Embolism, 2015 - 2024(USD Billion)
    • 6.3. Atrial Fibrillation
      • 6.3.1. Global Thrombosis Drug Market for Atrial Fibrillation, 2015 - 2024(USD Billion)
    • 6.4. Deep Vein Thrombosis
      • 6.4.1. Global Thrombosis Drug Market for Deep Vein Thrombosis, 2015 - 2024(USD Billion)
  •  
  • Chapter 7. Global Thrombosis Drug Market - Distribution Channel Segment Analysis
    • 7.1. Global Thrombosis Drug Market: Indication overview
      • 7.1.1. Global Thrombosis Drug Market revenue share, by Distribution Channel, 2014 and 2024(USD Billion)
    • 7.2. Hospital Pharmacies
      • 7.2.1. Global Thrombosis Drug Market by Hospital Pharmacies, 2015 - 2024(USD Billion)
    • 7.3. Retail Pharmacies
      • 7.3.1. Global Thrombosis Drug Market by Retail Pharmacies, 2015 - 2024(USD Billion)
    • 7.4. Online Pharmacies
      • 7.4.1. Global Thrombosis Drug Market by Online Pharmacies, 2015 - 2024(USD Billion)
  •  
  • Chapter 8. Global Thrombosis Drug Market - Regional Segment Analysis
    • 8.1. Global Thrombosis Drug Market: Regional overview
      • 8.1.1. Global Thrombosis Drug Market revenue share, by Region, 2015 and 2024
    • 8.2. North America
      • 8.2.1. North America Thrombosis Drug Market revenue, by Drug, 2015 - 2024(USD Billion)
      • 8.2.2. North America Thrombosis Drug Market revenue, by Indication , 2015 - 2024(USD Billion)
      • 8.2.3. North America Thrombosis Drug Market revenue, by Distribution channel , 2015 - 2024(USD Billion)
      • 8.2.4. North America Thrombosis Drug Market revenue, by Region, 2015 - 2024(USD Billion)
      • 8.2.5. U.S.
        • 8.2.5.1. U.S. Thrombosis Drug Market revenue, by Drug, 2015 - 2024(USD Billion)
        • 8.2.5.2. U.S. Thrombosis Drug Market revenue, by Indication , 2015 - 2024(USD Billion)
        • 8.2.5.3. U.S. Thrombosis Drug Market revenue, by Distribution channel, 2015 - 2024(USD Billion)
        • 8.2.5.4. U.S. Thrombosis Drug Market revenue, by Region, 2015 - 2024(USD Billion)
      • 8.2.6. Rest of North America
        • 8.2.6.1. Rest of North America Thrombosis Drug Market revenue, by Drug, 2015 - 2024(USD Billion)
        • 8.2.6.2. Rest of North America Thrombosis Drug Market revenue, by Indication , 2015 - 2024(USD Billion)
        • 8.2.6.3. Rest of North America Thrombosis Drug Market revenue, by Distribution channel, 2015 - 2024(USD Billion)
        • 8.2.6.4. Rest of North America Thrombosis Drug Market revenue, by Region, 2015 - 2024(USD Billion)
    • 8.3. Europe
      • 8.3.1. Europe Thrombosis Drug Market revenue, by Drug, 2015 - 2024(USD Billion)
      • 8.3.2. Europe Thrombosis Drug Market revenue, by Indication , 2015 - 2024(USD Billion)
      • 8.3.3. Europe Thrombosis Drug Market revenue, by Distribution channel, 2015 - 2024(USD Billion)
      • 8.3.4. Europe Thrombosis Drug Market revenue, by Region, 2015 - 2024(USD Billion)
      • 8.3.5. Germany
        • 8.3.5.1. Germany Thrombosis Drug Market revenue, by Drug, 2015 - 2024(USD Billion)
        • 8.3.5.2. Germany Thrombosis Drug Market revenue, by Indication , 2015 - 2024(USD Billion)
        • 8.3.5.3. Germany Thrombosis Drug Market revenue, by Distribution channel, 2015 - 2024(USD Billion)
        • 8.3.5.4. Germany Thrombosis Drug Market revenue, by Region, 2015 - 2024(USD Billion)
      • 8.3.6. U.K.
        • 8.3.6.1. U.K. Thrombosis Drug Market revenue, by Drug, 2015 - 2024(USD Billion)
        • 8.3.6.2. U.K. Thrombosis Drug Market revenue, by Indication , 2015 - 2024(USD Billion)
        • 8.3.6.3. U.K. Thrombosis Drug Market revenue, by Distribution channel, 2015 - 2024(USD Billion)
        • 8.3.6.4. U.K. Thrombosis Drug Market revenue, by Region, 2015 - 2024(USD Billion)
      • 8.3.7. France
        • 8.3.7.1. France Thrombosis Drug Market revenue, by Drug, 2015 - 2024(USD Billion)
        • 8.3.7.2. France Thrombosis Drug Market revenue, by Indication , 2015 - 2024(USD Billion)
        • 8.3.7.3. France Thrombosis Drug Market revenue, by Distribution channel, 2015 - 2024(USD Billion)
        • 8.3.7.4. France Thrombosis Drug Market revenue, by Region, 2015 - 2024(USD Billion)
      • 8.3.8. Rest of Europe
        • 8.3.8.1. Rest of Europe Thrombosis Drug Market revenue, by Drug, 2015 - 2024(USD Billion)
        • 8.3.8.2. Rest of Europe Thrombosis Drug Market revenue, by Indication , 2015 - 2024(USD Billion)
        • 8.3.8.3. Rest of Europe Thrombosis Drug Market revenue, by Distribution channel, 2015 - 2024(USD Billion)
        • 8.3.8.4. Rest of Europe Thrombosis Drug Market revenue, by Region, 2015 - 2024(USD Billion)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Thrombosis Drug Market revenue, by Drug, 2015 - 2024(USD Billion)
      • 8.4.2. Asia Pacific Thrombosis Drug Market revenue, by Indication , 2015 - 2024(USD Billion)
      • 8.4.3. Asia Pacific Thrombosis Drug Market revenue, by Distribution channel, 2015 - 2024(USD Billion)
      • 8.4.4. Asia Pacific Thrombosis Drug Market revenue, by Region, 2015 - 2024(USD Billion)
      • 8.4.5. China
        • 8.4.5.1. China Thrombosis Drug Market revenue, by Drug, 2015 - 2024(USD Billion)
        • 8.4.5.2. China Thrombosis Drug Market revenue, by Indication , 2015 - 2024(USD Billion)
        • 8.4.5.3. China Thrombosis Drug Market revenue, by Distribution channel, 2015 - 2024(USD Billion)
        • 8.4.5.4. China Thrombosis Drug Market revenue, by Region, 2015 - 2024(USD Billion)
      • 8.4.6. Japan
        • 8.4.6.1. Japan Thrombosis Drug Market revenue, by Drug, 2015 - 2024(USD Billion)
        • 8.4.6.2. Japan Thrombosis Drug Market revenue, by Indication , 2015 - 2024(USD Billion)
        • 8.4.6.3. Japan Thrombosis Drug Market revenue, by Distribution channel, 2015 - 2024(USD Billion)
        • 8.4.6.4. Japan Thrombosis Drug Market revenue, by region, 2015 - 2024(USD Billion)
      • 8.4.7. India
        • 8.4.7.1. India Thrombosis Drug Market revenue, by Drug, 2015 - 2024(USD Billion)
        • 8.4.7.2. India Thrombosis Drug Market revenue, by Indication , 2015 - 2024(USD Billion)
        • 8.4.7.3. India Thrombosis Drug Market revenue, by Distribution channel, 2015 - 2024(USD Billion)
        • 8.4.7.4. India Thrombosis Drug Market revenue, by region, 2015 - 2024(USD Billion)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific Thrombosis Drug Market revenue, by Drug, 2015 - 2024(USD Billion)
        • 8.4.8.2. Rest of Asia Pacific Thrombosis Drug Market revenue, by Indication , 2015 - 2024(USD Billion)
        • 8.4.8.3. Rest of Asia Pacific Thrombosis Drug Market revenue, by Distribution channel, 2015 - 2024(USD Billion)
        • 8.4.8.4. Rest of Asia Pacific Thrombosis Drug Market revenue, by region, 2015 - 2024(USD Billion)
    • 8.5. Latin America
      • 8.5.1. Latin America Thrombosis Drug Market revenue, by Drug, 2015 - 2024(USD Billion)
      • 8.5.2. Latin America Thrombosis Drug Market revenue, by Indication , 2015 - 2024(USD Billion)
      • 8.5.3. Latin America Thrombosis Drug Market revenue, by Distribution channel, 2015 - 2024(USD Billion)
      • 8.5.4. Latin America Thrombosis Drug Market revenue, by Region, 2015 - 2024(USD Billion)
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil Thrombosis Drug Market revenue, by Drug, 2015 - 2024(USD Billion)
        • 8.5.5.2. Brazil Thrombosis Drug Market revenue, by Indication , 2015 - 2024(USD Billion)
        • 8.5.5.3. Brazil Thrombosis Drug Market revenue, by Distribution channel, 2015 - 2024(USD Billion)
        • 8.5.5.4. Brazil Thrombosis Drug Market revenue, by Region, 2015 - 2024(USD Billion)
      • 8.5.6. Rest of Latin America
        • 8.5.6.1. Rest of Latin America Thrombosis Drug Market revenue, by Drug, 2015 - 2024(USD Billion)
        • 8.5.6.2. Rest of Latin America Thrombosis Drug Market revenue, by Indication , 2015 - 2024(USD Billion)
        • 8.5.6.3. Rest of Latin America Thrombosis Drug Market revenue, by Distribution channel, 2015 - 2024(USD Billion)
        • 8.5.6.4. Rest of Latin America Thrombosis Drug Market revenue, by Region, 2015 - 2024(USD Billion)
    • 8.6. Middle East and Africa
      • 8.6.1. Middle East and Africa Thrombosis Drug Market revenue, by Drug, 2015 - 2024(USD Billion)
      • 8.6.2. Middle East and Africa Thrombosis Drug Market revenue, by Indication , 2015 - 2024(USD Billion)
      • 8.6.3. Middle East and Africa Thrombosis Drug Market revenue, by Distribution channel, 2015 - 2024(USD Billion)
      • 8.6.4. Middle East and Africa Thrombosis Drug Market revenue, by Region, 2015 - 2024(USD Billion)
  •  
  • Chapter 9. Company Profile
    • 9.1. GlaxoSmithKline Plc.
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Therapy portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. Aspen Pharmacare Holdings Limited
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Therapy portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. Johnson & Johnson
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Therapy portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. Sanofi
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Therapy portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. AstraZeneca Plc
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Therapy portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. Bayer AG
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Therapy portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. Boehringer Ingelheim GmbH
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Therapy portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. Bristol-Myers Squibb Company
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Therapy portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments

Methodology

Free Analysis

Thrombosis is a condition in which blood gets a clot in the blood vessel, which leads to the obstruction of blood flow in the circulatory system and it may travel to the other body parts. Thrombosis drugs are those drugs which are used to treat the blood clots formed in the blood arteries and veins. These drugs generally include anticoagulant drugs and thrombin inhibitor drugs which dilute the blood and dissolve the blood clot in the arteries and veins and also reduce the chances of embolism. These drugs are available in the form of a capsule, tablet, and injection. As per the Center for Disease Control and Prevention report 2015, the exact number of people diagnosed with deep vein thrombosis or pulmonary embolism is not known, although it is estimated that 900,000 people could be affected (1 to 2 per 1,000) each year in the United States.

The major factors driving the growth of thrombosis drug market are increased the prevalence of thrombosis coupled with the availability of new products. As per the International Society on Thrombosis and Haemostasis report every year, there are approximately 10 million cases of venous thromboembolism recorded worldwide. There are various companies which are constantly working for the development of various new and effective drugs which is expected to provide better results as compared to conventional drugs. The companies have research and development department which helps in the development of these drugs and further launch of new drugs in the area of treatment are further expected to promote the growth of thrombosis treatment market. Moreover, unmet needs of people and significant technological advancements in the healthcare sectors and new product launches are expected to fuel the growth of thrombosis drug market. However, increased use of generic drugs is expected to hamper the growth of thrombosis drug market over the forecast period.

Global Thrombosis Drug Market

Thrombosis drug market is segmented on the basis of drug class such as Factor Xa Inhibitor, Low Molecular Weight Heparin, and P2Y12 Platelet Inhibitor. Factor Xa Inhibitor segment is expected to dominate the thrombosis drug market over the forecast period. Based on the indication, the thrombosis drug market is segmented into pulmonary embolism, atrial fibrillation, and deep vein thrombosis. Pulmonary embolism is expected to dominate the thrombosis drug market in the near future. Based on the distribution channel, the thrombosis drug market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Over the forecast period, hospital pharmacies are expected to dominate the thrombosis drug market.

Based on the region, the global thrombosis drug market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to dominate the thrombosis drug market in the near future which is closely followed by Europe owing to the various technological advancement and increased prevalence of thrombosis. The Asia Pacific is expected to expand moderately over the forecast period. Latin America and the Middle East & Africa are expected to develop considerably. 

Some of the major key players of thrombosis drug market include GlaxoSmithKline Plc., Aspen Pharmacare Holdings Limited, Johnson & Johnson, Sanofi, AstraZeneca Plc, Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Baxter International Inc., and Pfizer, Inc., among others.

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Accept

We have secured system to process your transaction.


We Are On Social